This is the authors' abstract. We don't add key points for this paper.
Our results indicate that the stability of STI IN/DNA complexes is an important parameter that must be taken into account when evaluating dolutegravir resistance. This study confirms that a pathway including N155H can be selected in patients treated with dolutegravir with the help of the polymorphic K156N that acts as a secondary mutation that enhances the resistance to dolutegravir.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Malet et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: